89 related articles for article (PubMed ID: 17276659)
1. Modulation of innate and adaptive immunity by lactoferrin in human immunodeficiency virus (HIV)-infected, antiretroviral therapy-naïve children.
Zuccotti GV; Vigano A; Borelli M; Saresella M; Giacomet V; Clerici M
Int J Antimicrob Agents; 2007 Mar; 29(3):353-5. PubMed ID: 17276659
[TBL] [Abstract][Full Text] [Related]
2. Immune modulation by lactoferrin and curcumin in children with recurrent respiratory infections.
Zuccotti GV; Trabattoni D; Morelli M; Borgonovo S; Schneider L; Clerici M
J Biol Regul Homeost Agents; 2009; 23(2):119-23. PubMed ID: 19589293
[TBL] [Abstract][Full Text] [Related]
3. Innate immune defenses in HIV-1 infection: prospects for a novel immune therapy.
Montoya CJ; Rugeles MT; Landay AL
Expert Rev Anti Infect Ther; 2006 Oct; 4(5):767-80. PubMed ID: 17140354
[TBL] [Abstract][Full Text] [Related]
4. Distinct mechanisms for mitochondrial DNA loss in T and B lymphocytes from HIV-infected patients exposed to nucleoside reverse-transcriptase inhibitors and those naive to antiretroviral treatment.
Maagaard A; Holberg-Petersen M; Løvgården G; Holm M; Pettersen FO; Kvale D
J Infect Dis; 2008 Nov; 198(10):1474-81. PubMed ID: 18851688
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of interleukin-7 receptor (CD127) in HIV infection is associated with T cell activation and is a main factor influencing restoration of CD4(+) cells after antiretroviral therapy.
Benito JM; López M; Lozano S; González-Lahoz J; Soriano V
J Infect Dis; 2008 Nov; 198(10):1466-73. PubMed ID: 18847371
[TBL] [Abstract][Full Text] [Related]
6. Function of NKT cells, potential anti-HIV effector cells, are improved by beginning HAART during acute HIV-1 infection.
Vasan S; Poles MA; Horowitz A; Siladji EE; Markowitz M; Tsuji M
Int Immunol; 2007 Aug; 19(8):943-51. PubMed ID: 17702988
[TBL] [Abstract][Full Text] [Related]
7. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
[TBL] [Abstract][Full Text] [Related]
8. Bovine lactoferrin supplementation supports immune and antioxidant status in healthy human males.
Mulder AM; Connellan PA; Oliver CJ; Morris CA; Stevenson LM
Nutr Res; 2008 Sep; 28(9):583-9. PubMed ID: 19083463
[TBL] [Abstract][Full Text] [Related]
9. [Effect of opportunistic infections on the frequency of leukocyte subpopulations from type-1 human immunodeficiency virus infected individuals].
Ramírez Z; Cataño JC; Román A; Rugeles MT; Montoya CJ
Biomedica; 2008 Mar; 28(1):64-77. PubMed ID: 18645662
[TBL] [Abstract][Full Text] [Related]
10. Sustained immunologic and virologic efficacy after four years of highly active antiretroviral therapy in human immunodeficiency virus infected children in Thailand.
Puthanakit T; Aurpibul L; Oberdorfer P; Akarathum N; Kanjanavanit S; Wannarit P; Sirisanthana T; Sirisanthana V
Pediatr Infect Dis J; 2007 Oct; 26(10):953-6. PubMed ID: 17901804
[TBL] [Abstract][Full Text] [Related]
11. Mutation and control of the human immunodeficiency virus.
Stengel RF
Math Biosci; 2008 Jun; 213(2):93-102. PubMed ID: 18439629
[TBL] [Abstract][Full Text] [Related]
12. Long-term safety and effectiveness of ritonavir, nelfinavir, and lopinavir/ritonavir in antiretroviral-experienced HIV-infected children.
Rudin C; Burri M; Shen Y; Rode R; Nadal D; ;
Pediatr Infect Dis J; 2008 May; 27(5):431-7. PubMed ID: 18382386
[TBL] [Abstract][Full Text] [Related]
13. Oral manifestations in human immunodeficiency virus infected children in highly active antiretroviral therapy era.
dos Santos Pinheiro R; França TT; Ribeiro CM; Leão JC; de Souza IP; Castro GF
J Oral Pathol Med; 2009 Sep; 38(8):613-22. PubMed ID: 19614862
[TBL] [Abstract][Full Text] [Related]
14. Effects of vitamins, including vitamin A, on HIV/AIDS patients.
Mehta S; Fawzi W
Vitam Horm; 2007; 75():355-83. PubMed ID: 17368322
[TBL] [Abstract][Full Text] [Related]
15. Early therapy in HIV-1-infected children: effect on HIV-1 dynamics and HIV-1-specific immune response.
Zanchetta M; Anselmi A; Vendrame D; Rampon O; Giaquinto C; Mazza A; Accapezzato D; Barnaba V; De Rossi A
Antivir Ther; 2008; 13(1):47-55. PubMed ID: 18389898
[TBL] [Abstract][Full Text] [Related]
16. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
[TBL] [Abstract][Full Text] [Related]
17. Impaired phagocyte oxidative capacity in human immunodeficiency virus-infected children.
Hayani KC; Verral SC; Pitrak DL
J Infect Dis; 1999 Mar; 179(3):584-9. PubMed ID: 9952364
[TBL] [Abstract][Full Text] [Related]
18. Otitis media in Brazilian human immunodeficiency virus infected children undergoing antiretroviral therapy.
Miziara ID; Weber R; Araújo Filho BC; Pinheiro Neto CD
J Laryngol Otol; 2007 Nov; 121(11):1048-54. PubMed ID: 17319998
[TBL] [Abstract][Full Text] [Related]
19. The frequency, activation, and coreceptor expression of lymphocytes in human immunodeficiency virus/hepatitis C virus co-infected patients in China.
Shi W; Zhang Z; Zhang M; Liu J; Jiang Y; Wang Y; Jin X; Han X; Shang H
Jpn J Infect Dis; 2009 Jul; 62(4):284-8. PubMed ID: 19628906
[TBL] [Abstract][Full Text] [Related]
20. Immunologic features of HIV-1-infected women on HAART at delivery.
Ono E; Dos Santos AM; Machado DM; Succi RC; Amed AM; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2008 Jul; 74(4):236-43. PubMed ID: 18393385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
